ReviewClinical rheumatology2017

Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature.

Stefano Gentileschi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.